Alcohol Consumption Increases Risk Of Lobular And HR+ Breast Cancer
Olaparib, A PARP Inhibitor, Can Reduce Tumor Size In Advanced Ovarian Cancer
Brothers Of Prostate Cancer Patients At Risk Of Diagnosis
Estrogen Alone Didn’t Increase Lung Cancer Mortality In WHI
Tumors Harder To Detect In Women In Their Forties
Two Avastin Trials Show OS Benefit In Advanced Disease
Risk-Benefit Analysis Advised Prior To Hormone Therapy
Elderly Patients Fail To Receive New Cancer Therapy For CML
Rising Obesity May Result In Higher Cancer Incidence
Study Finds Relationship Between Meat Intake, Cancer
Radiation To Stem Cell Niche Improved PFS In Glioblastoma
NCI Cooperative Group Clinical Trials Approved
Trending Stories
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- Break Through Cancer’s Tyler Jacks: “We’ve created a new operating model for collaborative cancer research.”
- GRAIL presses on with Galleri test despite missed primary endpoint in pivotal study
Where GRAIL sees signals of benefit in the subgroups, screening experts see signs of overdiagnosis - Vinay Prasad, oncologist and Twitter star, locked in debate over precision medicine
- One result, two reactions: GRAIL’s Hall and NCI’s Castle react to negative NHS-Galleri trial outcome
- GRAIL’s Megan Hall: “I think we can be confident that there is clinical benefit to implementing this technology. And I think that’s really hard to argue with.”
Mainstream epidemiologists beg to differ
